Department of Immunobiology, University of Arizona, Tucson, AZ, 85724, USA.
Immun Ageing. 2012 Aug 15;9(1):17. doi: 10.1186/1742-4933-9-17.
The memory response to LCMV in mice persists for months to years with only a small decrease in the number of epitope specific CD8 T cells. This long persistence is associated with resistance to lethal LCMV disease. In contrast to studies focused on the number and surface phenotype of the memory cells, relatively little attention has been paid to the diversity of TCR usage in these cells. CD8+ T cell responses with only a few clones of identical specificity are believed to be relatively ineffective, presumably due to the relative ease of virus escape. Thus, a broad polyclonal response is associated with an effective anti-viral CD8+ T cell response.
In this paper we show that the primary CD8+ T cell response to the LCMV gp33-41 epitope is extremely diverse. Over time while the response remains robust in terms of the number of gp33-tetramer+ T cells, the diversity of the response becomes less so. Strikingly, by 26 months after infection the response is dominated by a small number TCRβ sequences. In addition, it is of note the gp33 specific CD8+ T cells sorted by high and low tetramer binding populations 15 and 22 months after infection. High and low tetramer binding cells had equivalent diversity and were dominated by a small number of clones regardless of the time tested. A similar restricted distribution was seen in NP396 specific CD8+ T cells 26 months after infection. The identical TCRVβ sequences were found in both the tetramerhi and tetramerlo binding populations. Finally, we saw no evidence of public clones in the gp33-specific response. No CDR3 sequences were found in more than one mouse.
These data show that following LCMV infection the CD8+ gp33-specific CD8 T cell response becomes highly restricted with enormous narrowing of the diversity. This narrowing of the repertoire could contribute to the progressively ineffective immune response seen in aging.
在小鼠中,针对 LCMV 的记忆反应可持续数月至数年,而针对表位特异性 CD8 T 细胞的数量仅略有下降。这种长期持续存在与抵抗致命性 LCMV 疾病有关。与专注于记忆细胞数量和表面表型的研究相比,相对较少关注这些细胞中 TCR 利用的多样性。具有少数相同特异性克隆的 CD8+T 细胞反应被认为相对无效,可能是由于病毒逃逸相对容易。因此,广泛的多克隆反应与有效的抗病毒 CD8+T 细胞反应相关。
在本文中,我们表明,针对 LCMV gp33-41 表位的初始 CD8+T 细胞反应极为多样化。随着时间的推移,尽管针对 gp33-四聚体+T 细胞的反应仍然很强烈,但反应的多样性却减少了。引人注目的是,在感染后 26 个月,反应主要由少数 TCRβ序列主导。此外,值得注意的是,在感染后 15 和 22 个月,通过高和低四聚体结合群体分选的 gp33 特异性 CD8+T 细胞。高和低四聚体结合细胞具有等效的多样性,并且无论测试时间如何,均由少数克隆主导。在感染后 26 个月,NP396 特异性 CD8+T 细胞中也观察到类似的受限分布。在四聚体高和低结合群体中都发现了相同的 TCRVβ 序列。最后,我们在 gp33 特异性反应中没有发现公共克隆的证据。在超过一只老鼠中都没有发现 CDR3 序列。
这些数据表明,在 LCMV 感染后,CD8+gp33 特异性 CD8 T 细胞反应变得高度受限,多样性大大缩小。这种反应谱的缩小可能导致衰老过程中逐渐无效的免疫反应。